JPH0351706B2 - - Google Patents

Info

Publication number
JPH0351706B2
JPH0351706B2 JP56209938A JP20993881A JPH0351706B2 JP H0351706 B2 JPH0351706 B2 JP H0351706B2 JP 56209938 A JP56209938 A JP 56209938A JP 20993881 A JP20993881 A JP 20993881A JP H0351706 B2 JPH0351706 B2 JP H0351706B2
Authority
JP
Japan
Prior art keywords
methyl
pyridazinone
dihydro
phenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56209938A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58113180A (ja
Inventor
Isao Kataue
Nobuyuki Fukazawa
Hajime Iizuka
Takashi Nishina
Joji Kamya
Yasuhito Tanaka
Takuo Nakano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Priority to JP56209938A priority Critical patent/JPS58113180A/ja
Priority to EP82306878A priority patent/EP0084250B1/en
Priority to DE8282306878T priority patent/DE3278688D1/de
Priority to US06/454,021 priority patent/US4521415A/en
Publication of JPS58113180A publication Critical patent/JPS58113180A/ja
Priority to US06/594,303 priority patent/US4523011A/en
Publication of JPH0351706B2 publication Critical patent/JPH0351706B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP56209938A 1981-12-28 1981-12-28 ピリダジノン誘導体 Granted JPS58113180A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP56209938A JPS58113180A (ja) 1981-12-28 1981-12-28 ピリダジノン誘導体
EP82306878A EP0084250B1 (en) 1981-12-28 1982-12-22 6-(substituted phenyl)-4,5-dihydro-3-(2h)-pyridazinone compounds and processes for their preparation
DE8282306878T DE3278688D1 (en) 1981-12-28 1982-12-22 6-(substituted phenyl)-4,5-dihydro-3-(2h)-pyridazinone compounds and processes for their preparation
US06/454,021 US4521415A (en) 1981-12-28 1982-12-28 6-(Substituted phenyl)-4,5-dihydro-3(2H)-pyridazinone compounds
US06/594,303 US4523011A (en) 1981-12-28 1984-03-28 Process for preparing 6-(substituted phenyl)-4,5-dihydro-3(2H)-pyridazinone compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56209938A JPS58113180A (ja) 1981-12-28 1981-12-28 ピリダジノン誘導体

Publications (2)

Publication Number Publication Date
JPS58113180A JPS58113180A (ja) 1983-07-05
JPH0351706B2 true JPH0351706B2 (en, 2012) 1991-08-07

Family

ID=16581142

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56209938A Granted JPS58113180A (ja) 1981-12-28 1981-12-28 ピリダジノン誘導体

Country Status (4)

Country Link
US (2) US4521415A (en, 2012)
EP (1) EP0084250B1 (en, 2012)
JP (1) JPS58113180A (en, 2012)
DE (1) DE3278688D1 (en, 2012)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734415A (en) * 1982-08-13 1988-03-29 Warner-Lambert Company Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones
JPS60126282A (ja) * 1983-12-14 1985-07-05 Mitsubishi Chem Ind Ltd ピリダジノン誘導体又はその塩類
HU193067B (en) * 1983-12-14 1987-08-28 Mitsubishi Chem Ind Process for the production of new pyridazinon-derivatives and of their salts
JPS60197672A (ja) * 1984-03-16 1985-10-07 Mitsubishi Chem Ind Ltd ビリダジノン誘導体またはその塩類
GB8400863D0 (en) * 1984-01-13 1984-02-15 Smith Kline French Lab Chemical compounds
JPS61158969A (ja) * 1984-12-24 1986-07-18 ワーナー‐ランバート・コンパニー ４，５‐ジヒドロ‐４，４‐ジアルキル‐６‐（置換）フエニル‐３（２ｈ）‐ピリダジノン類
AU578805B2 (en) * 1985-03-12 1988-11-03 Smith Kline & French Laboratories Limited Chemical compounds
US4962110A (en) * 1985-03-12 1990-10-09 Smith Kline & French Laboratories Limited Pyridazinone derivatives
CA1251448A (en) * 1985-03-27 1989-03-21 William J. Coates Pyridazinone derivatives
IL79280A (en) * 1985-07-05 1990-07-12 Smith Kline French Lab 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them
US4946842A (en) * 1985-07-05 1990-08-07 Smith Kline & French Laboratories Limited Novel guanidino pyridazinones as cardiac stimulants
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
DE3804490A1 (de) * 1988-02-12 1989-08-24 Heumann Pharma Gmbh & Co Substituierte 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AU621087B2 (en) * 1988-02-13 1992-03-05 Nippon Soda Co., Ltd. Pyridazinone derivatives
JP2717687B2 (ja) * 1988-02-13 1998-02-18 日本曹達株式会社 ピリダジノン誘導体及びその製造方法
GB8824458D0 (en) * 1988-10-19 1988-11-23 Orion Yhtymae Oy Substituted pyridazinones
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
CA2658821C (en) 2006-07-25 2014-10-21 Cephalon, Inc. Pyridizinone derivatives and uses thereof to treat diseases, disorders and/or conditions that may be mediated or modulated by inhibition of h3 receptors
US20110098933A1 (en) * 2009-10-26 2011-04-28 Nellcor Puritan Bennett Ireland Systems And Methods For Processing Oximetry Signals Using Least Median Squares Techniques
CN110117257B (zh) * 2018-02-05 2022-12-06 安徽省新星药物开发有限责任公司 一种含胍基的p2y12受体拮抗剂、制备方法及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975388A (en) * 1971-02-22 1976-08-17 Bdh Pharmaceuticals Limited Pyridazinones
BE790106A (fr) * 1971-10-14 1973-04-13 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
BE791539A (fr) * 1971-11-19 1973-05-17 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
US3947437A (en) * 1974-01-22 1976-03-30 The Dow Chemical Company Substituted pyridazinyloxy(thio)phenyl ureas and derivatives thereof
JPS5746966A (en) * 1980-09-03 1982-03-17 Mitsui Toatsu Chem Inc Pyridazinone derivative and its production

Also Published As

Publication number Publication date
DE3278688D1 (en) 1988-07-28
JPS58113180A (ja) 1983-07-05
US4523011A (en) 1985-06-11
US4521415A (en) 1985-06-04
EP0084250A3 (en) 1983-08-03
EP0084250A2 (en) 1983-07-27
EP0084250B1 (en) 1988-06-22

Similar Documents

Publication Publication Date Title
JPH0351706B2 (en, 2012)
CA1256107A (en) Pyrimidine derivatives, preparation thereof and use thereof
JP3182213B2 (ja) ピリミジンの新誘導体、それらの製造法、得られる中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
JPS6136831B2 (en, 2012)
JPH0210830B2 (en, 2012)
JPS6354714B2 (en, 2012)
JP2860689B2 (ja) ピリミジン誘導体
JPS6136260A (ja) 新規なイソインドリニル‐アルキル‐ピペラジン類およびその製法
JPH0377867A (ja) 新規オキサゾロピリジン誘導体
JPS60502003A (ja) 強心剤として有効な〔（ピリジニル）−２−ピリミジニル〕尿素及び同化合物を含む製剤
JPH0196180A (ja) ベンゾイミダゾール化合物、その製造法およびこれらの化合物を含有する心機能不全治療用組成物
KR20000032633A (ko) 신규의 피리미딘 유도체 및 그의 제조방법
WO1996020177A1 (en) Pyrimidine derivatives
JPH0528701B2 (en, 2012)
CN111285859B (zh) 一类以hiv-1逆转录酶为靶点的2,4,5-三取代嘧啶类化合物及其制备方法与应用
US4486431A (en) Cardiotonic use of 4,5-dihydro-6-(4-pyridinyl)-3(2H)-pyridazinones
JPH0546340B2 (en, 2012)
JP2996609B2 (ja) ピリミジン誘導体
WO1994003450A1 (en) Furylthiazole and their use as h2-receptor antagonists and antimicrobial agents
KR0181212B1 (ko) 비페닐 유도체 및 이의 제조방법
HU227255B1 (en) Novel piperidine-alkyl-amino-pyridazine derivatives, pharmaceutical compositions containing the same and process for the preparation of the active ingredient
PL438262A1 (pl) Pochodne N-[ω-(4-podstawione-piperazyn-1-ylo)alkilo]-1H-indazol-3-karboksyamidu, sposób ich otrzymywania oraz ich zastosowanie
JPH05271204A (ja) 新規なトリアジン誘導体
JPS61134389A (ja) トリアジノン誘導体および抗潰瘍剤
EP0189254A1 (en) Dihydropyridine anti-ischaemic and antihypertensive agents